Brightside Health, a provider of teletherapy services for depression, anxiety, and other mood disorders, has successfully raised $33 million in Series C funding. The round was led by S32 and included both existing and new investors such as Kennedy Lewis, Time BioVentures, and Anne Wojcicki’s Redwo

– New investors include InVivium Capital, Franklin Templeton, Point72, Eli Lilly and Company, and Alexandria Venture Investments –– Funds will be used to support ongoing and planned late-stage clinical development of CNS product candidates with four Phase 2 readouts expected across the nex